Nationwide Incretin Mimetics & Pancreatic Cancer Claims
Bad Drug Lawyer in Chicago, Illinois
Pintas & Mullins Law Firm is currently taking cases related to pancreatitis and pancreatic cancer from taking the diabetes drugs Byetta, Januvia, Janumet, and Victoza (known as incretim mimetics). Our Chicago drug injury attorneys are tough, experienced advocates for injury victims across the nation. With decades of experience and over 10,000 cases handled to date, you can rely on our accomplished lawyers.
What Are Incretin Mimetics & How Did They Hurt the Pancreas?
Incretins are a group of hormones made in the intestines. Incretin mimetics are drugs that mimic one specific incretin hormone, called GLP-1. In a healthy body, GLP-1 releases into the bloodstream when food passes through the intestines. The hormone then tells the pancreas to make insulin to control blood sugar levels.
Type 2 diabetes patients have low GLP-1 levels. Drugs like Byetta and Januvia mimic GLP-1, allowing diabetic patients to control their blood sugar levels.
The body is smart enough to know that incretin mimetic drugs are not, in fact, natural incretin hormones. When diabetic patients inject these drugs into their blood stream, their blood sugar levels normalize for the time being, but in doing so, harming the organs GLP-1 is supposed to communicate with.
Evidence of this harm is vast and growing. Studies show that pancreatic inflammation and enlargement among patients taking Byetta, Januvia and other incretin mimetics. This inflammation puts patients at risk for pancreatitis and cancerous cells and tumors.
According to a study conducted by John Hopkins University School of Medicine & Public Health, type 2 diabetes patients taking incretin mimetics face double the risk of developing pancreatitis than the average individual. Acute pancreatitis is a precursor to pancreatic cancer.
Another study from the Diabetes Center at the University of Florida and University of California, Los Angeles found that incretin drugs could cause an atypical and dangerous growth of the human pancreas, and may be linked to the development of neuroendocrine tumors.
Incretin mimetic drugs include:
Tough & Knowledgeable Chicago Drug Injury Lawyers on Your Side
To date, over 700 lawsuits have been consolidated into multi-district litigation in the Southern District of California (No. 2452). Defendants include the five manufacturers of these diabetes drugs.
Learn More About Drug Injury Lawsuits: Call Pintas & Mullins Law Firm
If you or a loved one suffered pancreatitis or pancreatic cancer after taking an incretin mimetic drug, we urge you to speak with a Chicago dangerous drug attorney as soon as possible. We can explain your rights and potential for compensation
Don’t wait to call—we’re available around-the-clock. Contact our office at (800) 774-7120 now to arrange a free consultation.